Literature DB >> 24664448

Nanofiber-coated drug eluting stent for the stabilization of mast cells.

Byeongtaek Oh1, Chi H Lee.   

Abstract

PURPOSE: The nanofiber-hydrogel blend containing nitric oxide (NO) donors and reactive oxygen species (ROS) scavengers (Edaravone: EDV) was explored as an advanced strategy for stabilization of Mast cells (MCs) to achieve efficient immune-suppressive effects.
METHODS: Three types of nanofiber hydrogel composites (Bare-Nanofibers (BNF), Nanofiber-Hydrogels (NF-Gel) and Cross-linked Nanofiber-Hydrogels (NF-Gel-X)), were evaluated. The degranulation rates of MCs were determined by measurement of the extracellular levels of hydrogen peroxide and the released amounts of β-hexosaminidase from the activated-MCs (a-MCs). In addition, the effects of EDV on the selective scavenging of the oxygen radicals and prevention of peroxynitrite formation were evaluated. The roles of a-MCs in re-endothelialization and viability of coronary artery endothelial cells (hPCAECs) were defined using alamar blue and LDH assay, respectively.
RESULTS: Each polymer matrix has unique morphological characteristics. The effects of EDV (~1.0 mM) on the production of NO were greatly influenced by the presence of superoxide or hydroxyl radicals. NF-G-X containing a mixture of EDV and S-Nitroglutathione (GSNO) produced the highest level of NO under the oxidative stress conditions. GSNO alone or a mixture of GSNO and EDV significantly lowered the degranulation rate of a-MCs (GSNO only: 55.8 ± 5.4%; GSNO with EDV: 50.6 ± 0.6%), indicating that NO plays an integral role in degranulation of a-MCs. There were no significant biochemical evidences of cytotoxic effects of GSNO and EDV on the hPCAECs.
CONCLUSIONS: Nanofibers containing a mixture of nitric oxide donors and ROS scavengers could be used as a promising strategy to stabilize MCs from the ROS-mediated immune responses.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24664448     DOI: 10.1007/s11095-014-1341-3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  42 in total

1.  Exposure of RBL-2H3 mast cells to Ag(+) induces cell degranulation and mediator release.

Authors:  Y Suzuki; T Yoshimaru; K Yamashita; T Matsui; M Yamaki; K Shimizu
Journal:  Biochem Biophys Res Commun       Date:  2001-05-11       Impact factor: 3.575

2.  pH-sensitive Eudragit nanoparticles for mucosal drug delivery.

Authors:  Jin-Wook Yoo; Namita Giri; Chi H Lee
Journal:  Int J Pharm       Date:  2010-10-31       Impact factor: 5.875

3.  Drug-eluting stent restenosis: an uncommon yet pervasive problem.

Authors:  Paul S Teirstein
Journal:  Circulation       Date:  2010-06-21       Impact factor: 29.690

4.  Nitric oxide inhibits IgE-dependent cytokine production and Fos and Jun activation in mast cells.

Authors:  Beverley J Davis; Brian F Flanagan; Alasdair M Gilfillan; Dean D Metcalfe; John W Coleman
Journal:  J Immunol       Date:  2004-12-01       Impact factor: 5.422

5.  Hydroxyl radical scavenging by edaravone derivatives: Efficient scavenging by 3-methyl-1-(pyridin-2-yl)-5-pyrazolone with an intramolecular base.

Authors:  Hidehiko Nakagawa; Ryo Ohyama; Ayako Kimata; Takayoshi Suzuki; Naoki Miyata
Journal:  Bioorg Med Chem Lett       Date:  2006-09-25       Impact factor: 2.823

Review 6.  Reactive oxygen species and mitochondrial diseases.

Authors:  I G Kirkinezos; C T Moraes
Journal:  Semin Cell Dev Biol       Date:  2001-12       Impact factor: 7.727

Review 7.  Oxidant signaling in vascular cell growth, death, and survival : a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling.

Authors:  K Irani
Journal:  Circ Res       Date:  2000-08-04       Impact factor: 17.367

8.  Cross-linked demineralized dentin maintains its mechanical stability when challenged by bacterial collagenase.

Authors:  Changqi Xu; Yong Wang
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2010-11-22       Impact factor: 3.368

9.  Evaluation of an in vitro method for the measurement of specific IgE antibody responses: the rat basophilic leukemia (RBL) cell assay.

Authors:  R J Dearman; R A Skinner; N Deakin; D Shaw; I Kimber
Journal:  Toxicology       Date:  2005-01-15       Impact factor: 4.221

10.  In vivo evaluation of vaginal films for mucosal delivery of nitric oxide.

Authors:  Jin-Wook Yoo; Gayathri Acharya; Chi H Lee
Journal:  Biomaterials       Date:  2009-05-05       Impact factor: 12.479

View more
  5 in total

1.  Targeting Ferroptosis Attenuates Inflammation, Fibrosis, and Mast Cell Activation in Chronic Prostatitis.

Authors:  Dongxu Lin; Mengyang Zhang; Changcheng Luo; Pengyu Wei; Kai Cui; Zhong Chen
Journal:  J Immunol Res       Date:  2022-06-17       Impact factor: 4.493

2.  Biomimicking Robust Hydrogel for the Mesenchymal Stem Cell Carrier.

Authors:  Byeongtaek Oh; Russell B Melchert; Chi H Lee
Journal:  Pharm Res       Date:  2015-04-25       Impact factor: 4.200

3.  Development of Thiolated-Graphene Quantum Dots for Regulation of ROS in macrophages.

Authors:  Byeongtaek Oh; Chi H Lee
Journal:  Pharm Res       Date:  2016-07-21       Impact factor: 4.200

4.  Computational Analysis on Down-Regulated Images of Macrophage Scavenger Receptor.

Authors:  Byeongtaek Oh; Yugyung Lee; Mingui Fu; Chi H Lee
Journal:  Pharm Res       Date:  2017-06-26       Impact factor: 4.200

Review 5.  Surface engineering at the nanoscale: A way forward to improve coronary stent efficacy.

Authors:  Aleena Mary Cherian; Shantikumar V Nair; Vijayakumar Maniyal; Deepthy Menon
Journal:  APL Bioeng       Date:  2021-06-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.